Intracoronary versus intravenous abciximab bolus in patients with ST-segment elevation myocardial infarction: 1-year results of the randomized AIDA STEMI trial.
J Am Coll Cardiol
; 62(13): 1214-5, 2013 Sep 24.
Article
in En
| MEDLINE
| ID: mdl-23850911
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immunoglobulin Fab Fragments
/
Platelet Aggregation Inhibitors
/
Antibodies, Monoclonal
/
Myocardial Infarction
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
J Am Coll Cardiol
Year:
2013
Document type:
Article
Country of publication:
United States